Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000056,plasma albumin level,,,,0.39,g/l,0.0082,0.02,MMO:0000351,automated plasma albumin analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77467,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood insulin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000358,serum insulin level,,,,0.000222,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67475,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood insulin amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000358,serum insulin level,,,,0.000301,mg/dl,0.0,1.0E-4,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66176,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood free fatty acid amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000547,serum free fatty acids level,,,,0.67,mmol/l,0.067,0.1773,MMO:0000308,serum free fatty acid analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,days,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67495,specific pathogen-free condition (for 210 days),fasting (for 1 days), 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood free fatty acid amount,,RS:0000364,F344/NSlc,male,217 days,9,,CMO:0000547,serum free fatty acids level,,,,0.64,mmol/l,0.058,0.174,MMO:0000308,serum free fatty acid analysis,,0,,,,,fasting,66184,fasting,, 1498,NBRP Hematology & Blood Biochemistry data,blood triglyceride amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000548,plasma triglyceride level,,,,1.4125,mmol/l,0.083,0.2034,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77473,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000658,epididymal fat pad weight to body weight ratio,,,,2.63,%,0.16,0.4233,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67491,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000026,blood hemoglobin level,,,,17,g/dl,0.2041,0.5,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77454,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000635,retroperitoneal fat pad weight to body weight ratio,,,,2.19,%,0.18,0.4762,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67471,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte size trait,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000038,mean corpuscular volume,,,,54.6,fl,0.4899,1.2,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77456,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",retroperitoneal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000356,retroperitoneal fat pad weight,,,,8.7,g,0.8,2.1166,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12781,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000037,hematocrit,,,,51.9,%,0.8981,2.2,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77455,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood glucose amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000046,blood glucose level,,,,78,mg/dl,2.6,6.879,MMO:0000113,oral glucose tolerance test,,0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12770,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149,mg/dl,3.52,9.313,MMO:0000113,oral glucose tolerance test,,0,,oral dose,120,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13160,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,157,mg/dl,5.21,13.7844,MMO:0000113,oral glucose tolerance test,,0,,oral dose,60,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13159,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,149.1,mg/dl,4.2,11.1122,MMO:0000113,oral glucose tolerance test,,0,,oral dose,30,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13158,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,134.1,mg/dl,4.7,12.435,MMO:0000113,oral glucose tolerance test,,0,,oral dose,15,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13157,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000046,blood glucose level,,,,99,mg/dl,4.48,11.853,MMO:0000113,oral glucose tolerance test,,0,,oral dose,0,min,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,13156,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,107.3,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,120,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13210,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,106,mg/dl,2.0,9.3808,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,90,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13209,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,112,mg/dl,2.2,10.3189,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,60,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13208,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,105.6,mg/dl,1.5,7.0356,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,30,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13207,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000046,blood glucose level,,,,87,mg/dl,1.2,5.6285,MMO:0000113,oral glucose tolerance test,tail,,"Arkray, Kyoto, Japan",gastric gavage,0,min,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",13206,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,108.4,mg/dl,14.5,38.3634,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13192,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000355,mesenteric fat pad weight,,,,7,g,0.7,1.852,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12780,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood cholesterol amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000363,serum total cholesterol level,,,,69.7,mg/dl,1.77,4.683,MMO:0000132,serum total cholesterol measurement test,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12775,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1498,NBRP Hematology & Blood Biochemistry data,blood creatinine amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000537,plasma creatinine level,,,,0.24,mg/dl,0.0041,0.01,MMO:0000354,automated plasma creatinine analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77476,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood cholesterol amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000585,plasma total cholesterol level,,,,53,mg/dl,1.2247,3.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77470,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood glucose amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000042,plasma glucose level,,,,144,mg/dl,2.0412,5.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77469,fasting (for 16 hours),, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000042,plasma glucose level,,,,80,mg/dl,3.1,9.3,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,0,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66172,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",epididymal fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000357,epididymal fat pad weight,,,,10.4,g,0.7,1.852,MMO:0000005,post excision weight measurement,,,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),12782,specific pathogen-free condition (for 210 days),fasting (for 1 days), 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,32.7,g/dl,0.3674,0.9,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77458,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",body mass,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000012,body weight,,,,393.6,g,6.2,16.4037,MMO:0000016,body weighing method,,,,oral glucose,0,min,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",12785,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",body mass,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000012,body weight,,,,386.4,g,6.5,30.4877,MMO:0000016,body weighing method,,,,,,,fasting (for 16 hours),11983,fasting (for 16 hours),, 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",body mass,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000012,body weight,,,,470.3,g,9.59,25.3728,MMO:0000016,body weighing method,,0,,,,,specific pathogen-free condition then fasting (for 16 hours),11607,specific pathogen-free condition,fasting (for 16 hours), 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000290,mean corpuscular hemoglobin level,,,,17.8,pg,0.0816,0.2,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77457,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood HDL cholesterol amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000646,plasma high density lipoprotein cholesterol level,,,,33.8,mg/dl,0.8573,2.1,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77471,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood LDL cholesterol amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000647,plasma low density lipoprotein cholesterol level,,,,5,mg/dl,0.0,0.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77472,fasting (for 16 hours),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",mesenteric fat pad mass,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000654,mesenteric fat pad weight to body weight ratio,,,,1.77,%,0.15,0.3969,MMO:0000005,post excision weight measurement,,0.0,,,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67467,specific pathogen-free condition (for 210 days),fasting (for 1 days), 230,"Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,22,,CMO:0000350,blood glucose level area under curve (AUC),,,,12619.8,(mg/dl) x min,142.8,669.7914,MMO:0000113,oral glucose tolerance test,tail,0.0,"Arkray, Kyoto, Japan",gastric gavage,,,"fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) ",67778,fasting (for 16 hours),"glucose solution, 2.8M (2 g/kg) ", 106,"Fuse M, et al., Physiol Genomics. 2008 Jul 8;.",blood glucose amount,,RS:0000364,F344/NSlc,male,420 days,7,,CMO:0000350,blood glucose level area under curve (AUC),,,,1.8,(mg/dl) x min,0.52,1.3758,MMO:0000113,oral glucose tolerance test,,0,trapezoid rule used for calculation,oral dose,,,specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) ,11606,specific pathogen-free condition,fasting (for 16 hours),glucose solution (2 g/kg) 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood glucose amount,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000350,blood glucose level area under curve (AUC),,,,12200,(mg/dl) x min,174.0,522.0,MMO:0000113,oral glucose tolerance test,,0,,gastric gavage,120,min,"fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) ",66174,fasting (between 16 and 18 hours),"glucose solution, 2.8M (2 g/kg) ", 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood adiponectin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000583,serum adiponectin level,,,,3.28,ng/ml,0.3,0.7937,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),67479,specific pathogen-free condition (for 210 days),fasting (for 1 days), 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood leptin amount,,RS:0000364,F344/NSlc,male,211 days,7,,CMO:0000780,serum leptin level,,,,5.46,ng/ml,1.06,2.8045,MMO:0000075,enzyme linked immunosorbent assay,,0.0,"ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN)",oral glucose,7,days,"specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) ",67483,specific pathogen-free condition (for 210 days),fasting (for 1 days),"glucose solution, 2.8M (2 g/kg) " 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",body mass,,RS:0000364,F344/NSlc,male,210 days,20,,CMO:0000012,body weight,,,,409.9,g,5.3,23.7023,MMO:0000016,body weighing method,,0,,,,,fasting (between 16 and 18 hours),66179,fasting (between 16 and 18 hours),, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",body mass,,RS:0000364,F344/NSlc,male,210 days,9,,CMO:0000012,body weight,,,,387.4,g,10.3,30.9,MMO:0000016,body weighing method,,0,,,,,fasting (between 16 and 18 hours),66178,fasting (between 16 and 18 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood urea nitrogen amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000586,plasma urea nitrogen level,,,,6.3189,mmol/l,0.1312,0.3213,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77475,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood total protein amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000054,plasma total protein level,,,,67,mg/ml,1.2247,3.0,MMO:0000356,automated plasma total protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77466,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,basophil quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000368,blood basophil count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77482,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood phosphate amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000058,plasma phosphate level,,,,7.9,mg/dl,0.1225,0.3,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77477,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000210,activated partial thromboplastin time,,,,13.8,s,0.4491,1.1,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),77462,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000211,prothrombin time,,,,15.9,s,0.0816,0.2,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),77461,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,eosinophil quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000369,blood eosinophil count to total leukocyte count ratio,,,,0,%,0.4082,1.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77483,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,lymphocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000371,blood lymphocyte count to total leukocyte count ratio,,,,83,%,1.633,4.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77486,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,monocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000374,blood monocyte count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77487,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood calcium amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000378,total plasma calcium level,,,,10.5,mg/dl,0.1225,0.3,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77478,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood alkaline phosphatase amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000045,plasma alkaline phosphatase activity level,,,,586,IU/l,12.2474,30.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77465,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000025,red blood cell count,,,,0.952,x 10E6 cells/ul,0.011,0.027,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77453,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000027,white blood cell count,,,,6.1,x 1000 cells/ul,0.4082,1.0,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77459,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,platelet quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000029,platelet count,,,,812,x 1000 cells/ul,9.798,24.0,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),77460,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood bilirubin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0002334,total plasma bilirubin level,,total plasma bilirubin level,,0.01,mg/dl,0.0041,0.01,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77474,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood sodium amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000060,plasma sodium level,,,,148.2,mmol/l,0.8573,2.1,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),77479,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood potassium amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000061,plasma potassium level,,,,3.87,mmol/l,0.0694,0.17,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),77480,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood chloride amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000059,plasma chloride level,,,,105,mmol/l,0.4082,1.0,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),77481,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood aspartate transaminase amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000043,plasma aspartate aminotransferase activity level,,,,69,U/l,1.2247,3.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77463,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood alanine transaminase amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0000044,plasma alanine aminotransferase activity level,,,,42,U/l,0.8165,2.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),77464,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0002337,blood segmented neutrophil count to total leukocyte count ratio,,segmented neutrophil %,,17,%,1.633,4.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77485,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0002342,plasma albumin to plasma total protein ratio,,plasma albumin to plasma total protein ratio,,1.42,,0.0204,0.05,MMO:0000352,automated plasma protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),77468,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0002339,non-specified leukocyte count to total leukocyte count ratio,,unidentified differential wbc,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77488,fasting (for 16 hours),, 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000364,F344/NSlc,male,70 days,6,,CMO:0002338,blood band neutrophil count to total leukocyte count ratio,,band neutrophil %,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),77484,fasting (for 16 hours),,